Vitrolife AB Stock Nasdaq Stockholm
Equities
SE0000816043
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.6B 332M | Sales 2025 * | 3.98B 366M | Capitalization | 21.34B 1.97B |
---|---|---|---|---|---|
Net income 2024 * | 530M 48.81M | Net income 2025 * | 677M 62.35M | EV / Sales 2024 * | 6.09 x |
Net Debt 2024 * | 600M 55.27M | Net cash position 2025 * | 103M 9.51M | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
40.3
x | P/E ratio 2025 * |
31.6
x | Employees | - |
Yield 2024 * |
0.86% | Yield 2025 * |
0.88% | Free-Float | 55.39% |
Latest transcript on Vitrolife AB
Managers | Title | Age | Since |
---|---|---|---|
Bronwyn Brophy
CEO | Chief Executive Officer | - | 23-07-31 |
Patrik Tolf
DFI | Director of Finance/CFO | 54 | 21-12-31 |
Chairman | 68 | 15-05-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 19-05-01 | |
Chairman | 68 | 15-05-06 | |
Director/Board Member | 64 | 18-04-26 |
1st Jan change | Capi. | |
---|---|---|
-1.14% | 12.59B | |
-12.53% | 7.42B | |
+0.86% | 5.35B | |
-1.37% | 4.51B | |
+5.16% | 4.47B | |
-51.93% | 3.21B | |
+11.34% | 2.71B | |
-11.07% | 1.73B | |
-6.06% | 1.63B |